-
Urgent: SMA Type 1 infant – Zolgensma access blocked due to cost
Hello everyone,
I am a father from Iran and caregiver of an infant with SMA Type 1.
Our doctor says funding must be secured before contacting Novartis for Zolgensma, which makes access impossible for our family.
Our case is registered in hospitals in Dubai and Qatar.
Has anyone here accessed:
• Early / Managed Access programs
• international treatment pathways
• advocacy or nonprofit support
Any guidance would mean everything to us.
Thank you.
Log in to reply.